Insider track record
Board DirectorNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Richo Anna, Director. Director active across 3 companies, notably Adamas Pharmaceuticals Inc. Cumulatively, 15 disclosures have been published. Activity tracked since 2 June 2021. The latest transaction was filed on 31 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Richo Anna
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
878 shares@ US$49.8212.9% of flowCommon stock- deferred stock unitsSEC:0001199306-26-000004:0
940 shares@ US$43.878.8% of flowCommon stock- deferred stock unitsSEC:0001199306-26-000002:0
950 shares@ US$43.439.7% of flowCommon stock- deferred stock unitsSEC:0001199306-25-000005:0
954 shares@ US$43.2510.7% of flowCommon stock- deferred stock unitsSEC:0001109357-25-000154:0
3,780 shares0Common StockSEC:0001127602-25-015506:0
933 shares@ US$44.1915.0% of flowCommon stock- deferred stock unitsSEC:0001109357-25-000090:0
1,119 shares@ US$36.8715.6% of flowCommon stock- deferred stock unitsSEC:0001109357-25-000010:0
1,025 shares@ US$40.2314.5% of flowCommon stock- deferred stock unitsSEC:0001109357-24-000168:0
1,161 shares@ US$35.5415.1% of flowCommon stock- deferred stock unitsSEC:0001109357-24-000142:0
2,622 shares0Common StockSEC:0001127602-24-016276:0
1,131 shares@ US$36.4815.0% of flowCommon stock- deferred stock unitsSEC:0001109357-24-000090:0
1,052 shares@ US$39.2114.6% of flowCommon stock- deferred stock unitsSEC:0001109357-24-000014:0
674 shares@ US$40.5810.2% of flowCommon stock- deferred stock unitsSEC:0001109357-23-000081:0
25,000 sharesCommon StockSEC:0001328143-21-000088:0
5,000 shares0Common StockSEC:0001328143-21-000061:0
About Richo Anna
RICHO ANNA is an Administrateur who has filed 15 filings in total. Across the 15 recent filings observed, they relate to EXELON CORP, Illumina, INC. and Adamas Pharmaceuticals Inc, with transaction nature mainly Attributions, and the buy and sell amounts shown are both EUR 0. The period covered by these filings runs from 2021-06-04 to 2026-04-01.